25.03.2013 Views

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Nevertheless, both studies were of sufficient clinical and epidemiological similarity to<br />

attempt statistical pooling. Unfortunately, neither study examined the same outcomes in<br />

the same way, and individual data points are not given with which to manipulate<br />

statistically the effect measures for transformation on a common scale. Therefore, the<br />

review did not attempt a pooled estimate of treatment effect. Instead a brief description<br />

of results of the two studies follows.<br />

Review of published clinical experience<br />

Nighoghossian et al79 assessed functional outcome at six and 12 months using three<br />

scales: the Orgogozo, 81 Rankin disability, 82 and Trouillas scales. The latter was developed<br />

specifically for this study. The Orgogozo scale was a 100-point quantitative scale with a<br />

score of 100 as normal. It was the only scale used to measure baseline values. In the<br />

Rankin and Trouillas scales, a score of zero was considered normal.<br />

The authors found statistically significant differences between the intervention and<br />

comparison groups at 1 year based on the Orgogozo and Trouillas scores (Table 45).<br />

However, pre- and post-therapeutic differences were not statistically apparent on all<br />

scales.<br />

Table 45 Functional neurologic scores in intervention and comparison groups with cerebrovascular<br />

disease according to follow-up (Nighoghossian et al). 79<br />

Mean Score Treatment Difference<br />

Scale and Time of<br />

Examination Intervention Group Comparison<br />

Group<br />

Orgogozo<br />

Baseline<br />

6 months<br />

12 months<br />

Trouillas<br />

6 months<br />

12 months<br />

Rankin<br />

6 months<br />

12 months<br />

42.5 (5.1) †<br />

72.9 (6.6)<br />

78.2 (6.4)<br />

4.6 (0.5)<br />

4.1 (0.6)<br />

2.6 (0.2)<br />

2.4 (0.2)<br />

* Baseline comparisons were made for the Orgogozo scale only.<br />

† Figures in parentheses are standard errors.<br />

31.5 (5.3)<br />

54.7 (5.3)<br />

50.3 (8.7)<br />

6.1 (0.7<br />

6.3 (0.7)<br />

3.2 (0.3)<br />

3.0 (0.3)<br />

Intervention less<br />

Comparison<br />

11.0 (7.4)<br />

18.2 (10.6)<br />

27.9 (10.8)<br />

–1.5 (0.9)<br />

–2.2 (1.0)<br />

–0.6 (0.4)<br />

–0.6 (0.4)<br />

Anderson et al 80 used a graded neurological examination scale that was sensitive to<br />

deficits referable to the region of the brain perfused by branches of the internal carotid<br />

artery. 83 A score of 100 was considered normal. Examinations were administered on<br />

enrolment, at five days, six weeks, four months (the primary outcome of interest), and<br />

one year.<br />

The authors report that comparison therapy patients improved by (Mean ± SEM) 15.9 ±<br />

3.2 points (p < 0.0003) while the intervention group experiences an improvement in<br />

scores by 12.2 ± 4.8 points (p < 0.03). Due to the trend of better improvement in the<br />

comparison group compared to the HBO-exposed group, the study was suspended for<br />

ethical reasons.<br />

48 <strong>Hyperbaric</strong> oxygen therapy<br />

p<br />

0.15<br />

0.10<br />

0.02<br />

0.19<br />

0.03<br />

0.13<br />

0.11

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!